StonvexLoading…
StonvexStonvexStonvexCore line items from BWA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $14.32B | $14.09B | $14.20B | $12.63B |
Operating Income | $536.00M | $546.00M | $1.16B | $1.01B |
Net Income | $277.00M | $338.00M | $625.00M | $944.00M |
EPS (Diluted) | $1.28 | $1.50 | $2.67 | $3.99 |
Total Assets | $13.77B | $13.99B | $14.45B | $16.99B |
Total Liabilities | $8.15B | $8.29B | $8.39B | $9.49B |
Cash & Equivalents | $2.31B | $2.09B | $1.53B | $1.34B |
Free Cash Flow OCF − CapEx | $1.18B | $711.00M | $565.00M | $947.00M |
Shares Outstanding | 207.06M | 218.67M | 229.78M | 234.12M |